findmyKOL
Clinical trialNCT06906341RecruitingPhase 2Interventional

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

SponsorCorcept TherapeuticsEnrollment270Endometrial CancerFallopian Tube CancerOvarian CancerPeritoneal Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • 328

    Aalst, Belgium

    Recruiting
  • 326

    Charleroi, Belgium

    Recruiting
  • 325

    Hasselt, Belgium

    Recruiting
  • 108

    Leuven, Belgium

    Recruiting
France
  • 306

    Lille, France

    Recruiting
  • 307

    Nancy, France

    Recruiting
  • 310

    Nice, France

    Recruiting
  • 324

    Pierre-Bénite, France

    Recruiting
  • 323

    Plérin, France

    Recruiting
  • 308

    Toulouse, France

    Recruiting
Germany
  • 519

    Aachen, Germany

    Recruiting
  • 255

    Berlin, Germany

    Recruiting
  • 520

    Kempten, Germany

    Recruiting
Italy
  • 321

    Catania, Italy

    Recruiting
  • 122

    Milan, Italy

    Recruiting
  • 516

    Milan, Italy

    Recruiting
  • 295

    Pavia, Italy

    Recruiting
  • 124

    Rome, Italy

    Recruiting
  • 293

    Torino, Italy

    Recruiting
  • 319

    Treviso, Italy

    Recruiting
Poland
  • 341

    Gdynia, Poland

    Recruiting
  • 329

    Siedlce, Poland

    Recruiting
South Korea
  • 396

    Seoul, Gangnam-gu, South Korea

    Recruiting
  • 397

    Gyeonggi-do, Goyang-si, South Korea

    Recruiting
  • 399

    Seoul, Jongno-gu, South Korea

    Recruiting
  • 523

    Seoul, Seocho-gu, South Korea

    Recruiting
  • 398

    Seoul, Seodaemun-gu, South Korea

    Recruiting
  • 403

    Seoul, Songpa-gu, South Korea

    Recruiting
Spain
  • 349

    Badalona, Spain

    Recruiting
  • 115

    Barcelona, Spain

    Recruiting
  • 114

    Madrid, Spain

    Recruiting
  • 330

    Valencia, Spain

    Recruiting
  • 558

    Valencia, Spain

    Recruiting
United States
  • 004

    Birmingham, Alabama, United States

    Recruiting
  • 150

    Palo Alto, California, United States

    Recruiting
  • 014

    San Francisco, California, United States

    Recruiting
  • 544

    Fort Myers, Florida, United States

    Recruiting
  • 335

    Miami Beach, Florida, United States

    Recruiting
  • 543

    West Palm Beach, Florida, United States

    Recruiting
  • 518

    Minneapolis, Minnesota, United States

    Recruiting
9 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Apr 2025
Primary completion
31 Aug 2026
Completion
31 Dec 2026
Last update posted
14 Apr 2026
Registered enrollment
270
Registry id
NCT06906341

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.